Liu Zhengxue, Kundu-Roy Tanima, Matsuura Isao, Wang Guannan, Lin Yong, Lou You-Rong, Barnard Nicola J, Wang Xiao-Fan, Huang Mou-Tuan, Suh Nanjoo, Liu Fang
Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Oncotarget. 2016 Oct 4;7(40):64878-64885. doi: 10.18632/oncotarget.11713.
Previous studies based on cell culture and xenograft animal models suggest that Smad3 has tumor suppressor function for breast cancer during early stages of tumorigenesis. In this report, we show that DMBA (7,12-dimethylbenz[a]anthracene), a chemical carcinogen, induces mammary tumor formation at a significantly higher frequency in the Smad3 heterozygous mice than in the Smad3 wild type mice. This is the first genetic evidence showing that Smad3 inhibits mammary tumor formation in a mouse model. Our findings support the notion that Smad3 has important tumor suppressor function for breast cancer.
以往基于细胞培养和异种移植动物模型的研究表明,Smad3在肿瘤发生的早期阶段对乳腺癌具有肿瘤抑制功能。在本报告中,我们发现化学致癌物7,12-二甲基苯并[a]蒽(DMBA)诱导Smad3杂合小鼠乳腺肿瘤形成的频率显著高于Smad3野生型小鼠。这是首个在小鼠模型中表明Smad3抑制乳腺肿瘤形成的遗传学证据。我们的研究结果支持Smad3对乳腺癌具有重要肿瘤抑制功能这一观点。